Effect of maleimide-polyethylene glycol hemoglobin (mp4) on hemodynamics and acid-base status after uncontrolled hemorrhage in anesthetized swine: Comparison with crystalloid and blood

Journal of Trauma

Volumn 63, Issue 6, 2007, Pages 1234-1244

  Young, Mark A ^a   Riddez, Louis ^a,b,c,e   Winslow, B Thomas ^d,e  

^a SANGART INC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

^e SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

Author keywords

Blood substitutes; Hemoglobin; Hemorrhage; Hemospan; MP4; PEG; Shock

Indexed keywords

CRYSTALLOID SOLUTIONS; HEMOGLOBIN; ISOTONIC SOLUTION; MACROGOL DERIVATIVE; MALEIMIDE DERIVATIVE; MALEIMIDE POLYETHYLENE GLYCOL MODIFIED HEMOGLOBIN, MP4; MALEIMIDE-POLYETHYLENE GLYCOL-MODIFIED HEMOGLOBIN, MP4; UNCLASSIFIED DRUG;

ACID BASE BALANCE; ANIMAL; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HEMODYNAMICS; MALE; METHODOLOGY; RESUSCITATION; SWINE;

ACID-BASE EQUILIBRIUM; ANIMALS; BLOOD TRANSFUSION; FEMALE; HEMODYNAMICS; HEMOGLOBINS; HEMORRHAGE; ISOTONIC SOLUTIONS; MALE; MALEIMIDES; POLYETHYLENE GLYCOLS; RESUSCITATION; SWINE;

EID: 38949119470     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/TA.0b013e31815bd7b0     Document Type: Article

References (68)

1. Pope A, French G, Longnecker DE. Fluid Resuscitation. State of the Science for Treating Combat Casualties and Civilian Injuries. Washington, DC: National Academy Press; 1999.
2. Moore FA, McKinley BA, Moore EE. The next generation in shock resuscitation. Lancet. 2004;363:1988-1996.
3. Boldt J. New light on intravascular volume replacement regimens: What did we learn from the past three years? Anesth Analg. 2003;97:1595-1604.
4. Alderson P, Bunn F, Lefebvre C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004;CD001208.
5. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-2256.
6. Proctor KG. Blood substitutes and experimental models of trauma. J Trauma. 2003;54:S106-S109.
7. Creteur J, Vincent JL. Hemoglobin solutions. Crit Care Med. 2003;31:S698-S707.
8. Stowell CP. Hemoglobin-based oxygen carriers. Curr Opin Hematol. 2002;9:537-543.
9. Winslow RM. Blood Substitutes. London: Elsevier, Inc.; 2006.
10. Winslow R. MP4, a new non-vasoactive polyethylene glycol-hemoglobin conjugate. Artif Organs. 2004;28:806.
11. Winslow R. Oxygen transport agents: a new approach to red blood cell alternatives. TATM. 2004;5:498-504.
12. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock. A randomized controlled efficacy trial. JAMA. 1999;282:1857-1864.
13. Saxena R, Wijnhoud AD, Carton H, et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke. 1999;30:993-996.
14. Greenburg AG, Kim HW. Hemoglobin based oxygen carriers. Crit Care. 2004;8:S61-S64.
15. Hemosol Inc. Hemosol Announces Second Quarter 2003 Financial Results. Available at: http://www.hemosol.com/presspop.cfm?newsID=2164.
16. Hess J, Macdonald V, Brinkley W. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol. 1993;74:1769-1778.
17. Vane LA, Funston J, Kirschner R, et al. Comparison of transfusion with DCHLb or pRBCs for treatment of intraoperative anemia in sheep. J Appl Physiol. 2002;92:343-353.
18. Winslow RM. αα-Crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang. 2000;79:1-20.
19. Vandegriff K, Malavalli A, Wooldridge J, Lohman J, Winslow R. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion. 2003;43:509-516.
20. Wettstein R, Tsai A, Erni D, Winslow R, Intaglietta M. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med. 2003;31:1824-1830.
21. 2 therapeutics. Am J Physiol. 2003;285:H1411-H1419.
22. Winslow RM, Gonzales A, Gonzales M, et al. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. J Appl Physiol. 1998;85:993-1003.
23. Winslow RM, Lohman J, Malavalli A, Vandegriff KD. Comparison of PEG-modified albumin and hemoglobin in extreme hemodilution in the rat. J Appl Physiol. 2004;97:1527-1534.
24. Drobin D, Kjellstrom B, Malm E, et al. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4). J Appl Physiol. 2004;96:1843-1853.
25. Young M, Riddez L, Kjellstrom T, et al. MalPEG-hemoglobin (MP4) improves hemodynamics, acid-base status, and survival after uncontrolled hemorrhage in anesthetized swine. Crit Care Med. 2005;33:1794-1804.
26. Olofsson C, Ahl T, Johansson T, et al. A multi-center clinical study of the safety and activity of maleimide-polyethylene glycol hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. Anesthesiology. 2006;105:1153-1163.
27. Kveim M, Nesbakken R. Utilization of exogenous acetate during canine haemorrhagic shock. Scand J Clin Lab Invest. 1979;39:653-658.
28. Matsuda H, Sakurai T, Iino M, Nakayama N. Comparative study on the effects of acetate Ringer's solution, lactated Ringer's solution, Ringer's solution and 5% glucose-acetated Ringer's solution on canine hemorrhagic shock. J Anesth. 1994;8:326-333.
29. Kusuoka H, Hoffman JIE. Advice on statistical analysis for circulation research. Circ Res. 2002;91:662-671.
30. Dunlap E, Farrell L, Nigro C, Estep T, Marchand G, Burhop K. Resuscitation with diaspirin crosslinked hemoglobin in a pig model of hemorrhagic shock. Artif Cells Blood Substit Immobil Biotechnol. 1995;23:39-61.
31. Marchand G, Dunlap E, Farrell L, Nigro C, Burhop K. Resuscitation with increasing doses of diaspirin crosslinked hemoglobin in swine. Artif Cells Blood Substit Immobil Biotechnol. 1996;24:469-487.
32. McNeil CJ, Smith LD, Jenkins LD, York MG, Josephs MJ. Hypotensive resuscitation using a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) leads to reversal of anaerobic metabolism. J Trauma. 2001;50:1063-1075.
33. York GB, Eggers JS, Smith DL, et al. Low-volume resuscitation with a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) provides adequate tissue oxygenation for survival in a porcine model of controlled hemorrhage. J Trauma. 2003;55:873-885.
34. Sampson JB, Davis MR, Mueller DL, Kashyap VS, Jenkins DH, Kerby JD. A comparison of the hemoglobin-based oxygen carrier HBOC-201 to other low-volume resuscitation fluids in a model of controlled hemorrhagic shock. J Trauma. 2003;55:747-754.
35. Malhotra AK, Kelly ME, Miller PR, Hartman JC, Fabian TC, Proctor KG. Resuscitation with a novel hemoglobin-based oxygen carrier in a Swine model of uncontrolled perioperative hemorrhage. J Trauma. 2003;54:915-924.
36. Maxwell RA, Gibson JB, Fabian TC, Proctor KG. Resuscitation of severe chest trauma with four different hemoglobin-based oxygen-carrying solutions. J Trauma. 2000;49:200-209.
37. Biopure Corp. U.S. Navy's IND For Proposed 'RESUS' Trauma Trial on Hold Pending Response to FDA. Available at: http://www.corporate-ir.net/ireye/ir.site.zhtml?ticker=bpurandscript=418andlayout=0anditem_id=728994.
38. Kramer G, Nascimento P, Vaid S. Hemoglobin-based oxygen carriers as resuscitative solutions for trauma and combat casualty care. In: Winslow R, ed. Blood Substitutes. London: Elsevier, Inc.; 2006:139-151.
39. Winslow R, Chapman K, Vandegriff K, Young M. Hemospan (MP4), a human hemoglobin modified with maleimide-polyethlene glycol. In: Winslow R, ed. Blood Substitutes. London: Elsevier, Inc.; 2006:470-482.
40. Lieberthal W, Fuhro R, Alam H, et al. Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions. Shock. 2002;17:61-69.
41. Matheson B, Razynska A, O'Hearne M, Bucci E. Renal response to hemodilution with albumin or crosslinked bovine hemoglobin: role of nitric oxide. J Lab Clin Med. 1998;132:47-53.
42. Doss DN, Estafanous FG, Ferrario CM, Brum JM, Murray PA. Mechanism of systemic vasodilation during normovolemic hemodilution. Anesth Analg. 1995;81:30-34.
43. Doherty DH, Doyle MP, Curry SR, et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nature Biotechnology. 1998;16:672-676.
44. Johnson P. Local regulation of blood flow. In: Winslow R, ed. Blood Substitutes. London: Elsevier, Inc.; 2006;102-111.
45. 2. Am J Physiol Heart Circ Physiol. 2003;285:H1600-H1608.
46. Cabrales P, Tsai A. Plasma viscosity regulates systemic and microvascular perfusion during acute extreme anemic conditions. Am J Physiol Heart Circ Physiol. 2006;291:2445-2452.
47. Rohlfs RJ, Bruner E, Chiu A, et al. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem. 1998;273:12128-12134.
48. Tsai AG, Cabrales P, Acharya S, Manjula BN, Winslow RM, Intaglietta M. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood. 2006;108:3603-3610.
49. Fitzpatrick CM, Savage SA, Kerby JD, Clouse W, Kashyap VS. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage. J Am Coll Surg. 2004;199:693-701.
50. Winslow R. Current status of blood substitute research: towards a new paradigm. J Int Med. 2003;253:508-517.
51. Qin X, Kwansa H, Bucci E, Roman RJ, Koehler RC. Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin. J Appl Physiol. 2006;100:336-342.
52. Sanui M, King DR, Feinstein AJ, Varon AJ, Cohn SM, Proctor KG. Effects of arginine vasopressin during resuscitation from hemorrhageic hypotension after traumatic brain injury. Crit Care Med. 2006;34:433-438.
53. Rizoli SB. Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma. 2003;54:S82-S88.
54. Siegel JH, Fabian M, Smith JA, Kingston EP, Steele KA, Wells MR. Oxygen debt criteria quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock. J Trauma. 2003;54:862-880.
55. Rixen D, Siegel JH. Bench-to-bedside review: oxygen debt and its metabolic correlates as quantifiers of the severity of hemorrhagic and post-traumatic shock. Crit Care. 2005;9:441-453.
56. Siegel JH. Through a glass darkly: the lung as a window to monitor oxygen consumption, energy metabolism, and severity of critical illness. Clin Chem. 1990;36:1585-1593.
57. Siegel JH, Fabian M, Smith JA, Costantino D. Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma. 1997;42:199-212.
58. Vandegriff K, Rohlfs R, Winslow R. Colloid osmotic effects of hemoglobin-based oxygen carriers. In: Winslow R, Vandegriff K, Intaglietta M, eds. Advances in Blood Substitutes: Industrial Opportunities and Medical Challenges. Boston: Birkhauser; 1997:207-232.
59. Migita R, Gonzales A, Gonzales ML, Vandegriff KD, Winslow RM. Blood volume and cardiac index in rats after 50% exchange transfusion with hemoglobin-based oxygen carriers. J Appl Physiol. 1997;82:1995-2002.
60. Fischer SR, Burnet M, Traber DL, Prough DS, Kramer GC. Plasma volume expansion with solutions of hemoglobin, albumin, and Ringer lactate in sheep. Am J Physiol. 1999;276:H2194-H2203.
61. Lurie F, Jahr JS, Driessen B. Changes in circulating blood and plasma volume after hemoglobin-based oxygen carrier infusion and additional infusion of colloid solutions. Amer J Therapeutics. 2002;9:425-430.
62. Young MA, Malavalli A, Winslow N, Vandergriff KD, Winslow RM. Toxicity and hemodynamic effects after single dose administration of MalPEG-hemoglobin(MP4) in rhesus monkeys. Transl Res. 2007;149:333-342.
63. Rafie AD, Rath PA, Michell MW, et al. Hypotensive resuscitation of multiple hemorrhages using crystalloid and colloids. Shock. 2004;22:262-269.
64. Fitzpatrick CM, Biggs KL, Atkins BZ, et al. Prolonged low-volume resuscitation with HBOC-201 in a large-animal survival model of controlled hemorrhage. J Trauma. 2005;59:273-283.
65. Toramen F, Evrenkaya S, Yuce M, et al. Highly positive intraoperative fluid balance during cardiac surgery is associated with adverse outcome. Perfusion. 2004;19:85-91.
66. Joshi GP. Interoperative fluid restriction improves outcome after major elective gastrointestinal surgery. Anesth Analg. 2005;101:601-605.
67. Biopure Corp. Press Release, July 12, 2006; Biopure comments on Wall Street Journal articles.
68. Northfield Laboratories, Inc. Press Release, March 20, 2006; Northfield Laboratories Releases Summary Observations from Its Elective Surgery Trial